Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker, Nicholas D. James, Christopher D. Brawley, Noel W. Clarke, Alex P. Hoyle, Adnan Ali, Alastair W.S. Ritchie, Gerhardt Attard, Simon Chowdhury, William Cross, David P. Dearnaley, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar I. Malik, Malcolm D. Mason, David Matheson, Robin Millman, J. Martin RussellGeorge N. Thalmann, Claire L. Amos, Roberto Alonzi, Amit Bahl, Alison Birtle, Omar Din, Hassan Douis, Chinnamani Eswar, Joanna Gale, Melissa R. Gannon, Sai Jonnada, Sara Khaksar, Jason F. Lester, Joe M. O'Sullivan, Omi A. Parikh, Ian D. Pedley, Delia M. Pudney, Denise J. Sheehan, Narayanan Nair Srihari, Anna T.H. Tran, Mahesh K.B. Parmar, Matthew R. Sydes*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
960Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial'. Together they form a unique fingerprint.